// App-Quantinova.ai

2066 : Next generation sequencing (NGS) of primary central nervous system tumors (CNST) as part of a personalized medicine cancer research program (PMRP) to identify alterations with sensitivity to targeted inhibitors.

Researchers

Presenter

  • Tara L. Benkers

Principal Investigators

  • Anna Belinda Berry

  • Mariko Tameishi

  • Mary Lessig

  • Thomas David Brown

Medical Centers

  • Swedish Neuroscience Institute, Seattle, WA

  • CellNetix Pathology and Laboratories and Swedish Cancer Institute, Seattle, WA

  • Swedish Cancer Institute, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved